Neoadjuvant Therapy Clinical Trials

158 clinical trials for Neoadjuvant Therapy across international registries, including 48 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer（UPGRADE-TNBC） — RECRUITING · PHASE2
• Olaparib+Trastuzumab+Pertuzumab Neoadjuvant for Elderly HER2+ Breast Cancer — RECRUITING · PHASE4
• Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma — RECRUITING · PHASE2
• Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer — RECRUITING
• Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer. — RECRUITING · PHASE2
• Digital Mind-Body Therapy for Neoadjuvant Breast Cancer — RECRUITING · NA
• CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer — RECRUITING · PHASE2
• FAP-targeted PET/NIR in Lung Malignant Tumors — RECRUITING
• Circulating microRNAs and Response to Neoadjuvant Chemotherapy in Breast Cancer — RECRUITING
• Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLC — RECRUITING · PHASE2
• Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC） — RECRUITING
• Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer — RECRUITING · PHASE2
• To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study) — RECRUITING
• Perioperative Outcomes After Neoadjuvant Therapy in Colorectal Cancer — RECRUITING
• Iparomlimab and Tuvonralimab (QL1706) Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC — RECRUITING · PHASE2
• Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC — RECRUITING · PHASE2
• Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study — RECRUITING · NA
• No Axillary Surgical Treatment in Clinically Lymph Node Negative Patients on Ultrasonography After Neoadjuvant Chemotherapy — RECRUITING · PHASE3
• Sintilimab Plus Bevacizumab Biosimilar as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma — RECRUITING · PHASE2
• Sleeve Lobectomy Following Neoadjuvant Therapy in NSCLC — RECRUITING
• A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma — RECRUITING · PHASE1
• Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma — RECRUITING · PHASE2
• Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer — RECRUITING
• Neoadjuvant Toripalimab With or Without Celecoxib in dMMR/MSI-H Colorectal Cancer — RECRUITING · PHASE2
• Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05) — RECRUITING · PHASE2
• Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC) — RECRUITING · PHASE2
• Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUC — RECRUITING · PHASE2
• Neoadjuvant Tislelizumab + Nab-Paclitaxel Followed by Distal Ureterectomy for Ureteral Cancer — RECRUITING · PHASE2
• A Clinical Study on the Efficacy and Safety of Paclitaxel Polymeric Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma — RECRUITING · PHASE2
• Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer — RECRUITING · PHASE3
• Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma — RECRUITING · PHASE3
• Neoadjuvant SNF Precision Therapy Phase III — RECRUITING · PHASE3
• Adaptive Neoadjuvant Therapy for Esophageal Cancer — RECRUITING · NA
• Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined With Perioperative SOX for Intestinal Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma — RECRUITING · PHASE3
• Question Prompt List in Breast Cancer Patients Planned for Neoadjuvant Chemotherapy — RECRUITING · NA
• COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer — RECRUITING
• Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05) — RECRUITING · PHASE2
• Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally Advanced Rectal Cancer — RECRUITING · PHASE2
• Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients with Breast Cancer — RECRUITING · NA
• Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer — RECRUITING
• A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus — RECRUITING · PHASE1
• Multimodal Prehabilitation During Chemotherapy in Patients With Colorectal Liver Metastases — RECRUITING · NA
• A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma — RECRUITING · PHASE2
• Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC — RECRUITING · PHASE2
• Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC — RECRUITING · PHASE3
• Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer — RECRUITING · NA
• Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer — RECRUITING
• Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer — RECRUITING · PHASE2
• Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot Study — NOT_YET_RECRUITING · PHASE1
• Neoadjuvant Disitamab Vedotin, Toripalimab, and Radiotherapy for High-risk UTUC ( LUXUS07.1 ) — NOT_YET_RECRUITING · PHASE2

Refine this search